NUVB
Nuvation Bio Inc.Company with tickers: NUVB
CIK
1811063
CUSIP
67080N101
Shares Outstanding
346,685,831
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-06 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Convert | 100,000 |
| 2026-04-06 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell | 200,000 |
| 2026-04-06 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Convert | 100,000 |
| 2026-02-27 | Makunje Moses | SEE REMARKS | Award | 50,761 |
| 2026-02-27 | Makunje Moses | SEE REMARKS | Award | 224,439 |
| 2026-02-27 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Award | 748,130 |
| 2026-02-27 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Other | 53,000 |
| 2026-02-27 | Sjogren Colleen | Chief Commercial Officer | Award | 748,130 |
| 2026-02-27 | Sjogren Colleen | Chief Commercial Officer | Other | 84,000 |
| 2026-02-27 | Sauvage Philippe | Chief Financial Officer | Award | 748,130 |
| 2026-02-27 | Sauvage Philippe | Chief Financial Officer | Other | 12,673 |
| 2026-02-27 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Award | 748,130 |
| 2026-02-27 | Liu Dongfang | CHIEF MEDICAL OFFICER | Award | 748,130 |
| 2026-02-27 | Markel Stacy | CHIEF PEOPLE OFFICER | Award | 748,130 |
| 2026-02-27 | Markel Stacy | CHIEF PEOPLE OFFICER | Other | 32,591 |
| 2026-02-27 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Award | 748,130 |
| 2026-02-27 | Hung David | Director | Award | 1,995,012 |
| 2026-02-27 | Cui Xiangmin | Director | Award | 74,813 |
| 2025-12-01 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 150,000 |
| 2025-12-01 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 150,000 |
| 2025-12-01 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 150,000 |
| 2025-11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 10,000 |
| 2025-11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 10,000 |
| 2025-11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 10,000 |
| 2025-11-25 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 10,000 |
| 2025-11-25 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 10,000 |
| 2025-11-25 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 10,000 |
| 2025-11-20 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Convert | 69,051 |
| 2025-11-20 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 69,051 |
| 2025-11-20 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Convert | 69,051 |
| 2025-11-20 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 |
| 2025-11-20 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 20,000 |
| 2025-11-20 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 20,000 |
| 2025-11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 15,000 |
| 2025-11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 15,000 |
| 2025-11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 15,000 |
| 2025-11-19 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Sell | 200,000 |
| 2025-11-19 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Convert | 200,000 |
| 2025-11-19 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Convert | 200,000 |
| 2025-11-17 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 15,000 |
| 2025-11-17 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 15,000 |
| 2025-11-17 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 15,000 |
| 2025-10-27 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Convert | 100,000 |
| 2025-10-27 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Convert | 100,000 |
| 2025-10-27 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 100,000 |
| 2025-08-11 | Mashal Robert | Director | Gift | 350,001 |
| 2025-08-11 | Mashal Robert | Director | Gift | 350,001 |
| 2025-06-18 | Markel Stacy | CHIEF PEOPLE OFFICER | Buy | 10,000 |
| 2025-06-17 | Sauvage Philippe | Chief Financial Officer | Buy | 4,000 |
| 2025-06-16 | Sauvage Philippe | Chief Financial Officer | Buy | 3,300 |
| 2025-06-16 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy | 26,000 |
| 2025-06-16 | Hung David | Director | Buy | 500,000 |
| 2025-06-16 | Sjogren Colleen | Chief Commercial Officer | Buy | 50,000 |
| 2025-05-21 | FALBERG KATHRYN E | Director | Award | 292,983 |
| 2025-05-21 | Mashal Robert | Director | Award | 292,983 |
| 2025-05-21 | VERNON W ANTHONY | Director | Award | 292,983 |
| 2025-05-21 | BLICKENSTAFF KIM D | Director | Award | 292,983 |
| 2025-05-21 | Bazemore Robert B | Director | Award | 292,983 |
| 2025-05-02 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 |
| 2025-05-02 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 20,000 |
| 2025-05-02 | Liu Dongfang | CHIEF MEDICAL OFFICER | Convert | 20,000 |
| 2025-04-07 | Hung David | Director | Buy | 300,000 |
| 2025-04-04 | Hung David | Director | Buy | 200,000 |
| 2025-04-01 | Mashal Robert | Director | Buy | 1,100 |
| 2025-02-28 | Sjogren Colleen | Chief Commercial Officer | Award | 500,000 |
| 2025-02-28 | Sjogren Colleen | Chief Commercial Officer | Other | 28,000 |
| 2025-02-28 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Award | 500,000 |
| 2025-02-28 | Sauvage Philippe | Chief Financial Officer | Award | 500,000 |
| 2025-02-28 | Markel Stacy | CHIEF PEOPLE OFFICER | Award | 500,000 |
| 2025-02-28 | Markel Stacy | CHIEF PEOPLE OFFICER | Other | 16,591 |
| 2025-02-28 | Makunje Moses | SEE REMARKS | Award | 250,000 |
| 2025-02-28 | Makunje Moses | SEE REMARKS | Other | 15,275 |
| 2025-02-28 | Liu Dongfang | CHIEF MEDICAL OFFICER | Award | 500,000 |
| 2025-02-28 | Liu Dongfang | CHIEF MEDICAL OFFICER | Other | 12,000 |
| 2025-02-28 | Hung David | Director | Award | 2,000,000 |
| 2025-02-28 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Award | 500,000 |
| 2025-02-28 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Award | 500,000 |
| 2025-02-28 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Other | 18,000 |
| 2024-11-11 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Sell | 56,361 |
| 2024-11-11 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Other | 2,246,458 |
| 2024-10-08 | Mashal Robert | Director | Buy | 19 |
| 2024-10-07 | Sauvage Philippe | Chief Financial Officer | Award | 750,000 |
| 2024-10-07 | Sauvage Philippe | Chief Financial Officer | Other | 0 |
| 2024-09-04 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Other | 2,543,600 |
| 2024-09-04 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Other | 25,436 |
| 2024-09-04 | Cui Xiangmin | Director | Other | 967,100 |
| 2024-09-04 | Cui Xiangmin | Director | Other | 9,671 |
| 2024-09-03 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Award | 86,471 |
| 2024-09-03 | Wang Junyuan Jerry | Director, CEO, ANHEART THERAPEUTICS LTD. | Award | 25,436 |
| 2024-09-03 | BLICKENSTAFF KIM D | Director | Award | 200,801 |
| 2024-09-03 | Bazemore Robert B | Director | Award | 200,801 |
| 2024-09-03 | Cui Xiangmin | Director | Award | 32,877 |
| 2024-09-03 | Cui Xiangmin | Director | Award | 9,671 |
| 2024-09-03 | VERNON W ANTHONY | Director | Award | 200,801 |
| 2024-09-03 | FALBERG KATHRYN E | Director | Award | 200,801 |
| 2024-06-25 | Cui Xiangmin | Director | Buy | 277,895 |
| 2024-06-25 | Cui Xiangmin | Director | Other | 314,106 |
| 2024-06-24 | Cui Xiangmin | Director | Buy | 336,874 |
| 2024-06-21 | Cui Xiangmin | Director | Buy | 75,411 |
| 2024-06-20 | Cui Xiangmin | Director | Other | 314,106 |